TY - JOUR
T1 - Neurotensin analog NT77 induces regulated hypothermia in the rat
AU - Gordon, Christopher J.
AU - McMahon, Beth
AU - Richelson, Elliott
AU - Padnos, Beth
AU - Katz, Laurence
N1 - Funding Information:
We thank Drs. J. McKee and R. Carroll for their review of the manuscript. Supported in part by the Mayo Foundation for Medical Education and Research.
PY - 2003/10/3
Y1 - 2003/10/3
N2 - The potential use of hypothermia as a therapeutic treatment for stroke and other pathological insults has prompted the search for drugs that can lower core temperature. Ideally, a drug is needed that reduces the set-point for control of core temperature (Tc) and thereby induces a regulated reduction in Tc. To this end, a neurotensin analog (NT77) that crosses the blood brain barrier and induces hypothermia was assessed for its effects on the set-point for temperature regulation in the Sprague-Dawley rat by measuring behavioral and autonomic thermoregulatory responses. Following surgical implanation of radiotransmitters to monitor Tc, rats were placed in a temperature gradient and allowed to select from a range of ambient temperatures (Ta) while Tc was monitored by radiotelemetry. There was an abrupt decrease in selected Ta from 29 to 16°C and a concomitant reduction in Tc from 37.4 to 34. 0°C 1 hr after IP injection of 5.0 mg/kg NT77. Selected Ta and Tc then recovered to control levels by 1.5 hr and 4 hr, respectively. Oxygen consumption (M) and heat loss (H) were measured in telemetered rats housed in a direct calorimeter maintained at a Ta of 23.5°C. Injection of NT77 initially led to a reduction in M, little change in H, and marked decrease in Tc. H initially rose but decreased around the time of the maximal decrease in Tc. Overall, NT77 appears to induce a regulated hypothermic response because the decrease in Tc was preceded by a reduction in heat production, no change in heat loss, and preference for cold Ta's. Inducing a regulated hypothermic response with drugs such as NT77 may be an important therapy for ischemic disease and other insults.
AB - The potential use of hypothermia as a therapeutic treatment for stroke and other pathological insults has prompted the search for drugs that can lower core temperature. Ideally, a drug is needed that reduces the set-point for control of core temperature (Tc) and thereby induces a regulated reduction in Tc. To this end, a neurotensin analog (NT77) that crosses the blood brain barrier and induces hypothermia was assessed for its effects on the set-point for temperature regulation in the Sprague-Dawley rat by measuring behavioral and autonomic thermoregulatory responses. Following surgical implanation of radiotransmitters to monitor Tc, rats were placed in a temperature gradient and allowed to select from a range of ambient temperatures (Ta) while Tc was monitored by radiotelemetry. There was an abrupt decrease in selected Ta from 29 to 16°C and a concomitant reduction in Tc from 37.4 to 34. 0°C 1 hr after IP injection of 5.0 mg/kg NT77. Selected Ta and Tc then recovered to control levels by 1.5 hr and 4 hr, respectively. Oxygen consumption (M) and heat loss (H) were measured in telemetered rats housed in a direct calorimeter maintained at a Ta of 23.5°C. Injection of NT77 initially led to a reduction in M, little change in H, and marked decrease in Tc. H initially rose but decreased around the time of the maximal decrease in Tc. Overall, NT77 appears to induce a regulated hypothermic response because the decrease in Tc was preceded by a reduction in heat production, no change in heat loss, and preference for cold Ta's. Inducing a regulated hypothermic response with drugs such as NT77 may be an important therapy for ischemic disease and other insults.
KW - Behavioral thermoregulation
KW - Ischemic disease
KW - Neuropeptide
KW - Temperature regulation
UR - http://www.scopus.com/inward/record.url?scp=0042880751&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042880751&partnerID=8YFLogxK
U2 - 10.1016/S0024-3205(03)00663-5
DO - 10.1016/S0024-3205(03)00663-5
M3 - Article
C2 - 12967685
AN - SCOPUS:0042880751
SN - 0024-3205
VL - 73
SP - 2611
EP - 2623
JO - Life Sciences
JF - Life Sciences
IS - 20
ER -